Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070393 · ClinicalTrials.gov registry record · Early Phase 1
Breast-Sparing Proton Therapy for Hodgkin's Disease
A Early Phase 1 study, sponsored by Indiana University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT02070393 is a Early Phase 1 study that was terminated before completion, run by Indiana University. The registered enrollment target is 3 participants.
The verdict
NCT02070393, a Early Phase 1 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to drastically reduce unnecessary breast dose in young females with Hodgkin's Disease who require radiation therapy.
Interventions
- RADIATION Proton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02070393
The ClinicalTrials.gov registry entry for NCT02070393 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton is the first listed.
NCT02070393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02070393 about?
NCT02070393 is a clinical study titled "Breast-Sparing Proton Therapy for Hodgkin's Disease". The purpose of this study is to drastically reduce unnecessary breast dose in young females with Hodgkin's Disease who require radiation therapy.
What is the current status of trial NCT02070393?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2011-09. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02070393?
The interventions under investigation include: Proton (RADIATION).
Who is sponsoring clinical trial NCT02070393?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.